PHARMACEUTICAL COMPANY ALKERMES has announced that it is to reduce its staff by between 100 and 130 over the next two years.
The company said the decision was made following a reduction in demand “for certain pharmaceutical products that have become generic or are nearing the end of their commercial life”.
The company hopes to achieve the jobs losses through a combination of natural attrition, voluntary redundancy and compulsory redundancy.
Headquartered in Dublin, Alkermes currently employs 440 people between Dublin and Athlone.
Local TD Denis Naughten said it was a “dark day” and the job losses would “take approximately €4 million in wages out of the local economy”.
The pharmaceutical plant was formally known as Elan, but the businesses were combined in September 2011.
To embed this post, copy the code below on your site
have your say